RVPH (STOCKS)
REVIVA PHARMA HLDGS INC
$0.690000
+0.006100 (+0.89%)
Prev close: $0.683900
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Laxminarayan Bhat
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $79.92M
- Employees
- 14
- P/E (TTM)
- -7.79
- P/B (TTM)
- 3.78
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.46 | $-0.63 | +0.1744 | +27.49% |
|
Sep 2025 (Q3)
|
$-1.20 | $-1.98 | +0.7817 | +39.45% |
|
Jun 2025 (Q2)
|
$-2.40 | $-2.24 | -0.1560 | -6.95% |
|
Mar 2025 (Q1)
|
$-2.60 | $-3.72 | +1.1230 | +30.16% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $322.79K |
| Operating Expenses | $16.93M |
| Research and Development | $9.03M |
| Other Operating Expenses | $7.90M |
| Operating Income/Loss | -$16.93M |
| Income/Loss From Continuing Operations After Tax | -$16.63M |
| Income/Loss From Continuing Operations Before Tax | -$16.61M |
| Income Tax Expense/Benefit | $17.02K |
| Net Income/Loss | -$16.63M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$16.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$16.63M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.83 |
| Basic Average Shares | 76,037,066 |
| Assets | $23.56M |
| Current Assets | $23.56M |
| Noncurrent Assets | $0.00 |
| Liabilities | $6.12M |
| Current Liabilities | $6.12M |
| Accounts Payable | $2.09M |
| Wages | $408.52K |
| Other Current Liabilities | $3.63M |
| Noncurrent Liabilities | $0.00 |
| Equity | $17.44M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $17.44M |
| Liabilities And Equity | $23.56M |
| Net Cash Flow From Operating Activities | -$20.20M |
| Net Cash Flow From Operating Activities, Continuing | -$20.20M |
| Net Cash Flow From Investing Activities | -$16.90M |
| Net Cash Flow From Investing Activities, Continuing | -$16.90M |
| Net Cash Flow From Financing Activities | $37.10M |
| Net Cash Flow From Financing Activities, Continuing | $37.10M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$16.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.63M |
| Other Comprehensive Income/Loss | $0.00 |